EFFECTIVENESS OF ANTIBIOTIC THERAPY AND TONSILLECTOMY IN GUTTATE PSORIASIS MANAGEMENT

Authors

  • Abdurakhmanov Akhrorbek Avazbek ugli Senior Lecturer, Department of Dermatovenerology, Andijan State Medical Institute (ASMI)

Keywords:

Guttate psoriasis; antibiotic therapy; tonsillectomy; streptococcal infection; immune-mediated skin disease; psoriasis management

Abstract

Guttate psoriasis is an acute inflammatory variant of psoriasis that predominantly affects children and young adults and is frequently triggered by streptococcal upper respiratory tract infections. The strong temporal association between streptococcal tonsillopharyngitis and the onset or exacerbation of guttate psoriasis has led to increasing interest in therapeutic strategies aimed at eliminating infectious triggers. Among these strategies, antibiotic therapy and tonsillectomy have been proposed as adjunctive interventions in disease management.

This article reviews the current evidence regarding the clinical effectiveness of antibiotic therapy and tonsillectomy in the management of guttate psoriasis. Available studies suggest that antibiotic therapy may provide short-term clinical benefit in patients with confirmed active streptococcal infection by reducing antigenic stimulation and immune activation. However, antibiotics alone do not consistently prevent disease recurrence and should be used selectively to avoid unnecessary antimicrobial exposure.

Tonsillectomy has demonstrated promising long-term outcomes in selected patients with recurrent guttate psoriasis or chronic psoriasis associated with repeated streptococcal infections. Removal of the tonsillar tissue may decrease disease severity, reduce the frequency of flares, and lower the need for systemic psoriasis treatments. Nevertheless, evidence is largely derived from observational studies, and randomized controlled trials remain limited.

In conclusion, antibiotic therapy and tonsillectomy play complementary roles in the management of guttate psoriasis when streptococcal infection is implicated. Careful patient selection, microbiological confirmation, and integration with standard dermatological therapies are essential for optimizing treatment outcomes. Further high-quality studies are needed to establish evidence-based guidelines and clarify the long-term benefits of these interventions.

References

Telfer NR, Chalmers RJG, Whale K, Colman G. The role of streptococcal infection in psoriasis. British Journal of Dermatology. 1992;126(6):545–556.

Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B. Streptococcal throat infections and exacerbation of psoriasis. Journal of the American Academy of Dermatology. 2003;48(4):530–534.

Owen CM, Chalmers RJG, O'Sullivan T, Griffiths CEM. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. British Journal of Dermatology. 2001;145(6):886–890.

Sigurgeirsson B, Gudjonsson JE. Tonsillectomy and psoriasis. British Journal of Dermatology. 2013;168(2):237–242.

Nestle FO, Kaplan DH, Barker J. Psoriasis. New England Journal of Medicine. 2009;361(5):496–509.

Downloads

Published

2025-12-19

How to Cite

Abdurakhmanov Akhrorbek Avazbek ugli. (2025). EFFECTIVENESS OF ANTIBIOTIC THERAPY AND TONSILLECTOMY IN GUTTATE PSORIASIS MANAGEMENT. Ethiopian International Journal of Multidisciplinary Research, 12(12), 774–778. Retrieved from https://www.eijmr.org/index.php/eijmr/article/view/4305